 Connection
Shannon Kasperbauer to Humans
This is a "connection" page, showing publications Shannon Kasperbauer has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.189 |
|
|
|
-
Kasperbauer S, Thomson R. Things They Are a Changing in the Field of Nontuberculous Mycobacteria. Clin Chest Med. 2023 12; 44(4):xiii-xiv.
Score: 0.025
-
Tan S, Kasperbauer S. Nontuberculous Mycobacteria. Semin Respir Crit Care Med. 2021 08; 42(4):567-586.
Score: 0.021
-
Kasperbauer SH, Daley CL. Mycobacterium chimaera Infections Related to the Heater-Cooler Unit Outbreak: A Guide to Diagnosis and Management. Clin Infect Dis. 2019 03 19; 68(7):1244-1250.
Score: 0.018
-
Drummond WK, Kasperbauer SH. Nontuberculous Mycobacteria: Epidemiology and the Impact on Pulmonary and Cardiac Disease. Thorac Surg Clin. 2019 Feb; 29(1):59-64.
Score: 0.018
-
Holt MR, Kasperbauer S. Management of Extrapulmonary Nontuberculous Mycobacterial Infections. Semin Respir Crit Care Med. 2018 Jun; 39(3):399-410.
Score: 0.017
-
Hogan PE, Koelsch T, Daley CL, Kasperbauer SH. A Woman with a 15-Year History of Bronchiectasis and Recurrent Nontuberculous Mycobacterium Pulmonary Disease. Ann Am Thorac Soc. 2018 03; 15(3):380-382.
Score: 0.017
-
Kasperbauer SH, De Groote MA. The treatment of rapidly growing mycobacterial infections. Clin Chest Med. 2015 Mar; 36(1):67-78.
Score: 0.013
-
Kasperbauer S, Huitt G. Management of extrapulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013 Feb; 34(1):143-50.
Score: 0.012
-
Kasperbauer SH, Daley CL. Diagnosis and treatment of infections due to Mycobacterium avium complex. Semin Respir Crit Care Med. 2008 Oct; 29(5):569-76.
Score: 0.009
-
Flume PA, Griffith DE, Chalmers JD, Daley CL, Olivier K, O'Donnell A, Aksamit T, Kasperbauer S, Leitman A, Winthrop KL. Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration Workshop. Chest. 2021 02; 159(2):537-543.
Score: 0.005
-
George MP, Maier LA, Kasperbauer S, Eddy J, Mayer AS, Magin CM. How to Leverage Collaborations Between the BME Community and Local Hospitals to Address Critical Personal Protective Equipment Shortages During the COVID-19 Pandemic. Ann Biomed Eng. 2020 Sep; 48(9):2281-2284.
Score: 0.005
-
Holt MR, Kasperbauer SH, Daley CL. Serial sputum induction in nontuberculous mycobacterial pulmonary disease. Eur Respir J. 2020 06; 55(6).
Score: 0.005
-
Martiniano SL, Esther CR, Haworth CS, Kasperbauer SH, Zemanick ET, Caverly LJ. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis. Pediatr Pulmonol. 2020 02; 55(2):521-525.
Score: 0.005
-
Kwon YS, Levin A, Kasperbauer SH, Huitt GA, Daley CL. Efficacy and safety of tigecycline for Mycobacterium abscessus disease. Respir Med. 2019 Oct - Nov; 158:89-91.
Score: 0.005
-
Holt MR, Kasperbauer SH, Koelsch TL, Daley CL. Similar characteristics of nontuberculous mycobacterial pulmonary disease in men and women. Eur Respir J. 2019 07; 54(1).
Score: 0.005
-
Goldstein N, St Clair JB, Kasperbauer SH, Daley CL, Lindeque B. Nontuberculous Mycobacterial Musculoskeletal Infection Cases from a Tertiary Referral Center, Colorado, USA. Emerg Infect Dis. 2019 06; 25(6):1075-1083.
Score: 0.005
-
De Groote MA, Gibbs S, de Moura VC, Burgess W, Richardson K, Kasperbauer S, Madinger N, Jackson M. Analysis of a panel of rapidly growing mycobacteria for resistance to aldehyde-based disinfectants. Am J Infect Control. 2014 Aug; 42(8):932-4.
Score: 0.003
-
Kitada S, Levin A, Hiserote M, Harbeck RJ, Czaja CA, Huitt G, Kasperbauer SH, Daley CL. Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA. Eur Respir J. 2013 Aug; 42(2):454-60.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|